These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32633584)

  • 1. Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of
    Yagi T; Naito T; Kato A; Hirao K; Kawakami J
    Ann Pharmacother; 2021 Feb; 55(2):157-164. PubMed ID: 32633584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of
    Takanashi S
    Ann Pharmacother; 2022 Jan; 56(1):108-109. PubMed ID: 34013780
    [No Abstract]   [Full Text] [Related]  

  • 4. Warfarin interactions with antibiotics in the ambulatory care setting.
    Clark NP; Delate T; Riggs CS; Witt DM; Hylek EM; Garcia DA; Ageno W; Dentali F; Crowther MA;
    JAMA Intern Med; 2014 Mar; 174(3):409-16. PubMed ID: 24445404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
    Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
    J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study.
    Saito M; Hatakeyama S; Hashimoto H; Suzuki T; Jubishi D; Kaneko M; Kume Y; Yamamoto T; Suzuki H; Yotsuyanagi H
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):27. PubMed ID: 28399872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gefitinib on warfarin antithrombotic activity.
    Arai S; Mitsufuji H; Nishii Y; Onoda S; Ryuge S; Wada M; Katono K; Iwasaki M; Takakura A; Otani S; Yamamoto M; Yanaihara T; Yokoba M; Kubota M; Katagiri M; Fukui T; Kobayashi H; Yanase N; Hataishi R; Masuda N
    Int J Clin Oncol; 2009 Aug; 14(4):332-6. PubMed ID: 19705244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.
    Suzuki S; Ikegawa K; Yamamoto K; Saito S
    J Int Med Res; 2016 Oct; 44(5):1123-1130. PubMed ID: 27553806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
    Siegmund HU; Burghaus R; Kubitza D; Coboeken K
    Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of an Increase in Prothrombin Time-International Normalized Ratio by Interaction Between Warfarin and Baloxavir Marboxil in a Patient on Implantable Ventricular Assist Device.
    Kurosawa K; Takasaki S; Suzuki H; Sato Y; Akiyama M; Akiba M; Saiki Y; Mano N
    J Pharm Pharm Sci; 2021; 24():37-40. PubMed ID: 33460556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT; Byra W; Vaidyanathan S; Natarajan J; Ariyawansa J; Salih H; Turner KC
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.
    Garcia CB; Seguro LP; Perandini LA; de Sá Pinto AL; Lima FR; Negrão CE; Bonfa E; Borba EF
    Rheumatol Int; 2014 Dec; 34(12):1737-41. PubMed ID: 24825252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification.
    Hashimoto H; Saito M; Kanda N; Yamamoto T; Mieno M; Hatakeyama S
    BMC Pharmacol Toxicol; 2017 Nov; 18(1):74. PubMed ID: 29179737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.
    Ahmed A; Stephens JC; Kaus CA; Fay WP
    J Thromb Thrombolysis; 2008 Aug; 26(1):44-8. PubMed ID: 17985084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.